Unique and selective expression of l-amino acid transporter 1 in human tissue as well as being an aspect of oncofetal protein

Histology and Histopathology

Volumn 29, Issue 2, 2014, Pages 217-227

  Nakada, Norihiro ^a,b   Mikami, Tetuo ^a,b   Hana, Kiyomi ^c   Ichinoe, Masaaki ^a,b   Yanagisawa, Nobuyuki ^a,b   Yoshida, Tsutomu ^a   Endou, Hitoshi ^c,d   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c J Pharma Co   (Japan)

^d KYORIN UNIVERSITY   (Japan)

Author keywords

Human tissue; L amino acid transporter; Oncofetal protein

Indexed keywords

AMINO ACID TRANSPORTER; LAT2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADOLESCENT; AGE; AGED; ARTICLE; FEMALE; FETUS; GASTROINTESTINAL TRACT; HUMAN; INFANT; KIDNEY; MALE; METABOLISM; NEWBORN; OVARY; TESTIS; TISSUE DISTRIBUTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; AGE FACTORS; AGED; FEMALE; FETUS; GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MALE; OVARY; TESTIS; TISSUE DISTRIBUTION;

EID: 84892715302     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Babu E., Kanai Y., Chairoungdua A., Kim D.K., Iribe Y., Tangtrongsup S., Jutabha P., Li Y., Ahmed N., Sakamoto S., Anzai N., Nagamori S. and Endou H. (2003). Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J. Biol. Chem. 278, 43838-43845.
2. Blando J., Portis M., Benavides F., Alexander A., Mills G., Dave B., Conti C.J., Kim J. and Walker C.L. (2009). PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth. Am. J. Pathol. 174, 1869-1879.
3. Boado R.J., Li J.Y., Nagaya M., Zhang C. and Pardridge W.M. (1999). Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc. Natl. Acad. Sci. USA 96, 12079-12084.
4. Chrostowski M.K., McGonnigal B.G., Stabila J.P. and Padbury J.F. (2009). LAT-1 expression in pre-and post-implantation embryos and placenta. Placenta 30, 270-276.
5. Detta A. and Cruickshank G.S. (2009). L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res. 69, 2126-2132.
6. Fernández E., Torrents D., Chillarón J., Martín Del Río R., Zorzano A. and Palacín M. (2003). Basolateral LAT-2 has a major role in the transepithelial flux of L-cystine in the renal proximal tubule cell line OK. J. Am. Soc. Nephrol. 14, 837-47.
7. Fraga S., Pinho M.J. and Soares-da-Silva P. (2005). Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cells. Amino Acids 29, 229-233.
8. Gomes P. and Soares-da-Silva P. (2002). Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines. J. Membr. Biol. 186, 63-80.
9. Guertin D.A. and Sabatini D.M. (2007). Defining the role of mTOR in cancer. Cancer Cell 12, 9-22.
10. Hayashi K., Jutabha P., Endou H. and Anzai N. (2012). c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. Oncol. Rep. 28, 862-866.
11. Ichinoe M., Mikami T., Yoshida T., Igawa I., Tsuruta T., Nakada N., Anzai N., Suzuki Y., Endou H. and Okayasu I. (2011). High expression of L-type amino acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol. Int. 61, 281-289.
12. Imai H., Kaira K., Oriuchi N., Yanagitani N., Sunaga N., Ishizuka T., Kanai Y., Endou H., Nakajima T. and Mori M. (2009). L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology 54, 804-813.
13. Imai H., Kaira K., Oriuchi N., Shimizu K., Tominaga H., Yanagiotani N., Sunaga N., Ishizuka T., Nagamori S., Promchan K., Nakajima T., Yamamoto N., Mori M. and Kanai Y. (2010). Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res. 30, 4819-4828.
14. Kageyama T., Nakamura M., Matsuo A., Yamasaki Y., Takakura Y., Hashida M., Kanai Y., Naito M., Tsuruo T., Minato N. and Shimohama S. (2000). The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res. 879, 115-121.
15. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., Hisada T., Tanaka S., Ishizuka T., Kanai Y., Endou H., Nakajima T. and Mori M. (2008). L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci. 99, 2380-2386.
16. Kaira K., Oriuchi N., Imai H., Shimizu K., Yanagitani N., Sunaga N., Hisada T., Ishizuka T., Kanai Y., Nakajima T. and Mori M. (2009a). Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer 66, 120-126.
17. Kaira K., Oriuchi N., Shimizu K., Ishikita T., Higuchi T., Imai H., Yanagitani H., Sunaga N., Hisada T., Ishizuka T., Kanai Y., Endou H., Nakajima T., Endou K. and Mori M. (2009b). Evaluation of thoracic tumors with 18F-FMT and 18F-FDG PET-CT: a clinicopathological study. Int. J. Cancer 124, 1152-1160.
18. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E. and Endou H. (1998). Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273, 23629-23632.
19. Kim C.S., Cho S.H., Chun H.S., Lee S.Y., Endou H, Kanai Y. and Kim K.D. (2008). BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol. Pharm. Bull. 31, 1096-1100.
20. Kirchhoff P., Dave M.H., Remy C., Kosiek O., Busque S.M., Dufner M., Geibel J.P., Verrey F. and Wagner C.A. (2006). An amino acid transporter involved in gastric acid secretion. Pflugers Arch. 451, 738-748.
21. Kühne A., Kaiser R., Schirmer M., Heider U., Muhlke S., Niere W., Overbeck T., Hohloch K., Trumper L., Sezer O. and Brockmoller J. (2007). Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan. Pharmacogenet. Genomics 17, 505-517.
22. Lan H.Y., Mu W., Nikolic-Paterson D.J. and Atkins R.C. (1995). A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J. Histochem. Cytochem. 43, 97-102.
23. Lui W.Y., Mruk D., Lee W.M. and Cheng C.Y. (2003). Sertoli cell tight junction dynamics: their regulation during spermatogenesis. Biol. Reprod. 68, 1087-1097.
24. Maehama T. and Dixon J.E. (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-triphosphate. J. Biol. Chem. 273, 13375-13378.
25. Makrides V, Bauer R., Weber W., Wester H.J., Fischer S., Hinz R., Hunggel K., Opfermann B.T., Herzau M., Ganapathy V., Verrey F.and Brust P. (2007). Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain. Brain Res. 1147, 25-33.
26. Mann G.E., Yudilevich D.L. and Sobrevia L. (2003). Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol. Rev. 83, 183-252.
27. Matsuo H., Tsukada S., Nakata T., Chairoungdua A., Kim D.K., Cha S.H, Inatomi J., Yorifuji H., Fukuda J., Endou H. and Kanai Y. (2000) Expression of a system L neutral amino acid transporter at the blood-brain barrier. Neuroreport 11, 3507-3511.
28. Nakamura E., Sato M., Yang H., Miyagawa F., Harasaki M., Tomita K., Matsuoka S., Noma A., Iwai K. and Minato N. (1999). 4F2(CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer, J. Biol. Chem. 274, 3009-3016.
29. Nakanishi K., Matsuo H., Kanai Y., Endou H., Hiroi S., Tominaga S., Mukai M., Ikeda E., Ozeki Y., Aida S. and Kawai T. (2006). LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Virchows Arch. 448, 142-50.
30. Nawashiro H., Otani N., Shinomiya N., Fukui S., Ooigawa H., Shima K., Matsuo H., Kanai Y. and Endou H. (2006). L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int. J. Cancer 119, 484-492.
31. Nii T., Segawa H., Taketani Y., Tani Y., Ohkido M., Kishida S., Ito M., Endou H., Kanai Y., Takeda E. and Miyamoto K. (2001). Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation. Biochem. J. 358, 693-704.
32. Oda K., Hosoda N., Endo H., Saito K., Tsujihara K., Yamamura M., Sakata T., Anzai N., Wempe N.F., Kanai Y. and Endou H. (2010). L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci. 101, 173-179.
33. Ohno C., Nakanishi Y., Honma T., Henmi A., Sugitani M., Kanai Y. and Nemoto N. (2009) Significance of system L amino acid transporter 1 (LAT-1) and 4F2 heavy chain (4F2hc) expression in human developing intestine. Acta Histochem. Cytochem. 42, 73-81.
34. Pelletier R.M. and Byers S.W. (1992). The blood-testis barrier and Sertoli cell junctions: structural considerations. Microsc. Res. Tech. 20, 3-33.
35. Pineda M., Fernández E., Torrents D., Estevez R., Lopez C., Camps M., Lloberas J., Zorzano A. and Palacin M. (1999). Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J. Biol. Chem. 274, 19738-19744.
36. Prasad P.D., Wang H., Huang W., Kekuda R., Rajan D.P., Leibach F.H. and Ganapathy V. (1999). Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem. Biophys. Res. Commun. 255, 283-288.
37. Rossier G., Meier C., Bauch C., Summa V., Sordat B., Verrey F. and Kuhn L.C. (1999). LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine. J. Biol. Chem. 274, 34948-34954.
38. Sakata T., Ferdous G., Tsuruta T., Satoh T., Baba S., Muto T., Ueno A., Kanai Y., Endou H. and Okayasu I. (2009). L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol. Int. 59, 7-18.
39. Segawa H., Fukasawa Y., Miyamoto K., Takeda E., Endou H. and Kanai Y. (1999) Identification and functional characterization of a Na+ independent neutral amino acid transporter with broad substrate selectivity. J. Biol. Chem. 274, 19745-19751.
40. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P. and Mak T.W. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39.
41. Tomi M., Mori M., Tachikawa M., Katayama K, Terasaki T. and Hosoya K. (2005). L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier. Invest. Ophthalmol. Vis. Sci. 46, 2522-2530.
42. Uchino H., Kanai Y., Kim D.K., Wempe M.F., Chairoungdua A., Morimoto E., Anders M.W. and Endou H. (2002). Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol. Pharmacol. 61, 729-737.
43. Wang Q., Bailey C.G., Ng C., Tiffen J., Thoeng A., Minhas V., Lehman M.L., Hendy S.G., Buchanan G., Nelson C.G., Rasko J.E. and Holst J. (2011). Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Res. 71, 7525-7536.
44. Yamauchi K., Sakurai H., Kimura T., Wiriyasermkul P., Nagamori S., Kanai Y. and Kohno N. (2009). System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line. Cancer Lett. 276, 95-101.
45. Yanagida O., Kanai Y., Chairoungdua A., Kim D.K., Segawa H., Nii T., Cha S.H., Matsuo H., Fukushima J., Fukasawa Y., Tani Y., Taketani Y, Uchino H, Kim J.Y., Inatomi J, Okayasu I., Miyamoto K., Takeda E., Goya T. and Endou H. (2001). Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim. Biophys. Acta 1514, 291-302.
46. Yanagisawa N., Ichinoe M., Mikami T., Nakada N., Hana K,. Koizumi W., Endou H. and Okayasu I. (2012). High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal carcinomas. J. Clin. Pathol. 65, 1019-1023.
47. Yazama F. (2008) Continual maintenance of the blood-testis barrier during spermatogenesis: the intermediate compartment theory revisited. J. Reprod. Dev. 54. 299-305.
48. Zhou H., Ohno N., Terada N., Saitoh S., Fujii Y. and Ohno S. (2007). Involvement of follicular basement membrane and vascular endothelium in blood follicle barrier formation of mice revealed by 'in vivo cryotechnique. Reproduction 134, 307-317.